KTTAW Pasithea Therapeutics Corp. - Warrant
$0,01
Fiyat · Ağu 18, 2026
Temel veriler itibarıyla Ağu 14, 2026
52 Haftlık Aralık
$0–$0
48% of range
Analist Derecelendirmesi
—
Fiyat Hedefi
—
P/E (TTM)
—
ROE
-58.0%
Net Kâr Marjı
—
KTTAW Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$0.01
Piyasa Değeri
—
P/E (TTM)
—
EPS (TTM)
$-2.91
Gelir (TTM)
—
Temettü Verimi
—
ROE
-58.0%
D/E Borç/Özsermaye
—
52 Haftlık Aralık
$0 – $0
KTTAW Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Configure
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir ve Net Gelir
—
2021-12-31
→
2022-12-31
Hisse Başına Kâr
$-2.91
2021-12-31
→
2025-12-31
Serbest Nakit Akışı
—
2023-12-31
→
2023-12-31
Marjlar
—
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Metrik
5 Yıllık trend
KTTAW
Akran Ortalaması
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Metrik
5 Yıllık trend
KTTAW
Akran Ortalaması
ROA
-53.5%
—
ROE
-58.0%
—
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Metrik
5 Yıllık trend
KTTAW
Akran Ortalaması
Current Ratio (Cari Oran)
11.4
—
Quick Ratio (Cari Oran)
11.1
—
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Metrik
5 Yıllık trend
KTTAW
Akran Ortalaması
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Metrik
5 Yıllık trend
KTTAW
Akran Ortalaması
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 16
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue | · | · | · | $486.6K | $15.1K | |
| Cost of Revenue | · | · | · | $113.2K | $17.3K | |
| Gross Profit | · | · | · | · | $-2.2K | |
| R&D Expense | $8M | $7M | $8M | $3M | · | |
| SG&A Expense | $13M | $7M | $8M | $10M | $5M | |
| Operating Expenses | · | · | · | $697.1K | · | |
| Operating Income | $-21M | $-14M | $-16M | $-13M | $-5M | |
| Interest Expense | · | · | · | $102 | $508 | |
| Other Non-op | $7.0K | $345.4K | $471.6K | $861.1K | $2M | |
| Pretax Income | $-20M | $-14M | $-16M | $-12M | $-2M | |
| Net Income | $-20M | $-14M | $-16M | $-14M | $-2M | |
| EPS (Basic) | $-2.91 | $-12.69 | $-0.42 | $-1.76 | $-0.21 | |
| EPS (Diluted) | $-2.91 | $-12.69 | $-0.42 | $-1.76 | $-0.21 | |
| Shares (Basic) | 7,031,050 | 1,096,082 | 1,226,600 | 1,262,339 | 10,404,668 | |
| Shares (Diluted) | 7,031,050 | 1,096,082 | 1,226,600 | 1,262,339 | 10,404,668 | |
| EBITDA | $-21M | $-14M | $-16M | · | · |
Bilanço 21
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $55M | $7M | $16M | $33M | $53M | |
| Prepaid Expense | $811.5K | $302.6K | $215.9K | $562.4K | $333.8K | |
| Other Current Assets | $387.8K | $142.9K | $104.7K | $263.0K | · | |
| Current Assets | $56M | $7M | $17M | $34M | $53M | |
| PP&E (Net) | · | $122.3K | $141.2K | $125.2K | $20.1K | |
| PP&E (Gross) | · | $164.7K | $164.7K | $128.8K | $21.5K | |
| Accum. Depreciation | · | $42.4K | $23.5K | $3.6K | $1.4K | |
| Goodwill | · | $1M | $1M | $1M | · | |
| Intangibles | · | $7M | $8M | $9M | · | |
| Total Assets | $60M | $16M | $26M | $45M | $53M | |
| Accounts Payable | $1M | $1M | $3M | $1M | $447.3K | |
| Current Liabilities | $5M | $1M | $3M | $2M | $447.3K | |
| Capital Leases | · | · | · | $344.0K | · | |
| Total Liabilities | $5M | $1M | $3M | $3M | $2M | |
| Common Stock | $2.3K | $2M | $104 | $130 | $17.7K | |
| Paid-in Capital | $125M | $64M | $59M | $62M | $54M | |
| Retained Earnings | $-70M | $-50M | $-35M | $-19M | $-2M | |
| AOCI | $18.8K | $-7.2K | $-4.7K | $-661 | $-10.6K | |
| Stockholders' Equity | $55M | $15M | $23M | $42M | $51M | |
| Liabilities + Equity | $60M | $16M | $26M | $45M | $53M | |
| Shares Outstanding | 23,091,062 | 1,394,263 | 1,041,582 | 1,301,921 | 23,008,371 |
Nakit Akışı 10
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Stock-based Comp | $297.5K | $773.7K | $592.3K | $835.1K | $471.2K | |
| Operating Cash Flow | $-15M | $-14M | $-13M | $-12M | $-3M | |
| CapEx | · | · | $34.3K | $107.1K | $21.5K | |
| Investing Cash Flow | $11.0K | · | · | $-2M | $-21.5K | |
| Stock Issued | $2M | · | · | · | $1M | |
| Stock Repurchased | · | · | $4M | · | · | |
| Net Stock Activity | $2M | · | $-4M | · | · | |
| Financing Cash Flow | $64M | $5M | · | $-3M | $56M | |
| Net Change in Cash | $48M | $-9M | $-17M | $-20M | $53M | |
| Free Cash Flow | · | · | $-13M | · | · |
Kârlılık 2
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| ROA | -53.5% | -65.9% | -44.8% | · | · | |
| ROE | -58.0% | -85.3% | -61.7% | · | · |
Likidite ve Solventlik 2
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Current Ratio | 11.4 | 6.6 | 6.3 | · | · | |
| Quick Ratio | 11.1 | 6.2 | 6.2 | · | · |
Büyüme Oranları 1
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue YoY | · | · | · | 3130.4% | · |
Değerleme (TTM) 2
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | $486.6K | $15.1K | |
| Net Income TTM | $-20M | $-14M | $-16M | $-14M | $-2M |
Gelir Tablosu 15
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $218.6K | |
| Cost of Revenue | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $86.5K | |
| Gross Profit | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $132.1K | |
| R&D Expense | $4M | $3M | $3M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $1M | $1M | $1M | |
| SG&A Expense | $2M | $2M | $8M | $2M | $2M | $2M | $2M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | |
| Operating Income | $-6M | $-5M | $-10M | $-3M | $-4M | $-4M | $-3M | $-3M | $-4M | $-4M | $-5M | $-4M | $-4M | $-3M | $-4M | $-4M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | · | · | $-117.2K | $6.4K | · | · | |
| Other Non-op | · | · | $-14.2K | $7.0K | $7.0K | $7.0K | · | $4.8K | $114.4K | $153.2K | $184.1K | $176.7K | $117.2K | $-6.4K | $-55.6K | $-335.3K | |
| Pretax Income | $-5M | $-3M | $-10M | $-3M | $-4M | $-4M | $-3M | $-3M | $-4M | $-4M | $-5M | $-4M | $-4M | $-3M | $-4M | $-4M | |
| Net Income | $-5M | $-3M | $-10M | $-3M | $-4M | $-4M | $-3M | $-3M | $-4M | $-4M | $-5M | $-4M | $-4M | $-4M | $-5M | $-5M | |
| EPS (Basic) | $-0.16 | $-0.12 | $-0.23 | $-0.41 | $-0.66 | $-1.61 | $-2.41 | $-2.87 | $-3.71 | $-3.70 | $-0.40 | $0.00 | $-0.01 | $-0.01 | $-1.72 | $-0.01 | |
| EPS (Diluted) | $-0.16 | $-0.12 | $-0.23 | $-0.41 | $-0.66 | $-1.61 | $-2.41 | $-2.87 | $-3.71 | $-3.70 | $-0.40 | $0.00 | $-0.01 | $-0.01 | $-1.72 | $-0.01 | |
| Shares (Basic) | 32,100,063 | 24,337,812 | -8,264,985 | 7,443,577 | 5,641,251 | 2,211,207 | -2,033,853 | 1,044,144 | 1,043,312 | 1,042,479 | -2,641,503 | 1,258,050 | 1,306,401 | 1,303,652 | -71,738,855 | 26,548,688 | |
| Shares (Diluted) | 32,100,063 | 24,337,812 | -8,264,985 | 7,443,577 | 5,641,251 | 2,211,207 | -2,033,853 | 1,044,144 | 1,043,312 | 1,042,479 | -2,641,503 | 1,258,050 | 1,306,401 | 1,303,652 | -71,738,855 | 26,548,688 | |
| EBITDA | $-6M | $-5M | · | $-3M | $-4M | $-4M | · | $-3M | $-4M | $-4M | · | $-4M | $-4M | $-3M | · | $-4M |
Bilanço 23
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $46M | $50M | $55M | $4M | $7M | $5M | $7M | $9M | $8M | $12M | $16M | $20M | $27M | $30M | $33M | $42M | |
| Prepaid Expense | $2M | $2M | $811.5K | $1M | $1M | $621.2K | $302.6K | $319.3K | $570.2K | $1M | $215.9K | $985.1K | $814.6K | $835.8K | $562.4K | $1M | |
| Other Current Assets | $22.5K | $400.5K | $387.8K | $19.7K | $117.8K | $162.5K | $142.9K | $98.3K | $104.7K | $104.6K | $104.7K | $106.5K | $452.2K | $263.0K | $263.0K | $866.0K | |
| Current Assets | $48M | $53M | $56M | $6M | $9M | $6M | $7M | $10M | $9M | $13M | $17M | $21M | $28M | $31M | $34M | $44M | |
| PP&E (Net) | · | · | · | · | $113.6K | $117.5K | $122.3K | $127.1K | $131.8K | $136.5K | $141.2K | $145.9K | $173.3K | $174.9K | $125.2K | $340.5K | |
| PP&E (Gross) | · | · | · | · | $161.5K | $161.5K | $164.7K | $164.7K | $164.7K | $164.7K | $164.7K | $164.7K | · | · | $128.8K | $374.2K | |
| Accum. Depreciation | · | · | · | · | $47.9K | $44.0K | $42.4K | $37.6K | $32.9K | $28.2K | $23.5K | $18.8K | · | · | $3.6K | $33.7K | |
| Goodwill | · | · | · | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $4M | |
| Intangibles | · | · | $3M | $7M | $7M | $7M | · | $7M | $8M | $8M | $8M | $8M | $8M | $8M | $9M | $12.5K | |
| Total Assets | $52M | $56M | $60M | $14M | $17M | $15M | $16M | $19M | $18M | $22M | $26M | $31M | $38M | $42M | $45M | $50M | |
| Accounts Payable | $2M | $1M | $1M | $1M | $2M | $1M | $1M | $660.4K | $1M | $2M | $3M | $2M | $2M | $1M | $1M | $1M | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | · | · | $133.3K | $264.1K | · | · | |
| Current Liabilities | $2M | $1M | $5M | $1M | $2M | $2M | $1M | $660.4K | $1M | $2M | $3M | $2M | $2M | $2M | $2M | $2M | |
| Capital Leases | · | · | · | · | · | · | · | · | · | · | · | $210.8K | $256.1K | $300.5K | $344.0K | $724.4K | |
| Total Liabilities | $2M | $2M | $5M | $1M | $2M | $2M | $1M | $824.0K | $1M | $3M | $3M | $2M | $3M | $3M | $3M | $3M | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | · | $133.3K | $264.1K | · | · | |
| Common Stock | $3.3K | $2.5K | $2.3K | $743 | $743 | $270 | $139 | $104 | $104 | $104 | $104 | $17.5K | $18.0K | $18.0K | $130 | $18.0K | |
| Paid-in Capital | $128M | $128M | $125M | $72M | $72M | $66M | $64M | $64M | $59M | $59M | $59M | $59M | $62M | $62M | $62M | $58M | |
| Retained Earnings | $-78M | $-73M | $-70M | $-60M | $-57M | $-53M | $-50M | $-46M | $-43M | $-39M | $-35M | $-30M | $-27M | $-23M | $-19M | $-11M | |
| AOCI | $9.6K | $46.9K | $18.8K | $18.3K | $5.6K | · | $-7.2K | $-35.3K | $-8.2K | $-5.3K | $-4.7K | $-7.7K | $-3.5K | $-3.1K | $-661 | $-146.6K | |
| Stockholders' Equity | $50M | $55M | $55M | $12M | $15M | $13M | $15M | $18M | $16M | $20M | $23M | $28M | $36M | $39M | $42M | $47M | |
| Liabilities + Equity | $52M | $56M | $60M | $14M | $17M | $15M | $16M | $19M | $18M | $22M | $26M | $31M | $38M | $42M | $45M | $50M | |
| Shares Outstanding | 33,414,448 | 24,939,948 | 23,091,062 | 7,443,577 | 7,443,577 | 2,705,263 | 1,394,263 | 1,044,914 | 1,044,081 | 1,043,248 | 1,041,582 | 20,836,623 | 26,143,407 | 26,126,740 | 1,301,921 | 26,548,688 |
Nakit Akışı 11
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | $24.0K | · | · | · | $5.0K | · | · | · | · | · | · | · | · | |
| Stock-based Comp | $329.9K | $139.2K | $88.3K | $53.0K | $57.6K | $98.6K | $118.4K | $147.9K | $161.0K | $346.5K | $69.9K | $126.7K | $218.6K | $177.0K | $156.2K | $-16.1K | |
| Operating Cash Flow | $-5M | $-5M | $-5M | $-3M | $-4M | $-3M | $-2M | $-3M | $-4M | $-4M | $-3M | $-3M | $-3M | $-3M | $-3M | $-4M | |
| CapEx | · | · | · | · | · | · | · | · | · | · | $-36 | $-22.7K | $3.1K | $53.9K | $92.7K | $-137.8K | |
| Investing Cash Flow | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-230.4K | |
| Stock Issued | · | · | $-2M | $2M | $358.0K | $2M | · | · | · | · | · | · | · | · | · | · | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | $0 | · | · | · | · | · | |
| Net Stock Activity | · | · | · | · | · | $2M | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $8.5K | $750 | $56M | $-116.1K | $6M | $1M | $-23.6K | · | · | · | · | $-4M | $-130.8K | $264.1K | · | · | |
| Net Change in Cash | $-5M | $-5M | $51M | $-3M | $2M | $-2M | $-2M | $1M | $-4M | $-4M | $-3M | $-7M | $-3M | $-3M | $-9M | $-5M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | · | · | · | · | $-3M | · | · |
Kârlılık 7
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 60.5% | |
| Operating Margin | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | -1944.5% | |
| Net Margin | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | -2097.9% | |
| Pretax Margin | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | -2097.9% | |
| EBITDA Margin | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | -1944.5% | |
| ROA | -15.3% | -8.1% | · | -18.8% | -21.4% | -19.2% | · | -12.2% | -13.9% | -12.0% | · | -9.0% | -8.2% | -7.6% | · | -13.0% | |
| ROE | -16.2% | -8.5% | · | -20.2% | -23.7% | -21.7% | · | -13.0% | -14.9% | -13.1% | · | -9.6% | -8.6% | -7.9% | · | -14.5% |
Likidite ve Solventlik 4
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 26.2 | 35.4 | · | 4.0 | 5.0 | 3.8 | · | 14.8 | 6.2 | 5.3 | · | 10.2 | 12.6 | 14.7 | · | 29.4 | |
| Quick Ratio | 24.8 | 33.8 | · | 3.0 | 4.2 | 3.3 | · | 14.2 | 5.7 | 4.9 | · | 9.6 | 12.0 | 14.1 | · | 28.0 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | · | 32.7 | -502.9 | · | · |
Verimlilik 1
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.0 |
Değerleme (TTM) 7
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-15M | $-13M | · | $-13M | $-14M | $-14M | · | $-14M | $-15M | $-15M | · | $-15M | $-15M | $-12M | · | $-10M | |
| Market Cap | $364.2K | $271.8K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | -0.0 | -0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/B | 0.0 | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P / Tangible Book | 0.0 | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | · | -0.1 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -12385.3% | -25688.1% | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Gelir | — | — | — | $486.6K | $15.1K |
| Net Gelir | $-20M | $-14M | $-16M | $-14M | $-2M |
| Seyreltilmiş Hisse Başı Kâr | $-2.91 | $-12.69 | $-0.42 | $-1.76 | $-0.21 |
Bilanço
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Cari Oran | 11.4 | 6.6 | 6.3 | — | — |
| Cari Oran | 11.1 | 6.2 | 6.2 | — | — |
Nakit Akışı
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | — | — | $-13M | — | — |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
📊
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kurumsal Sahipler (13F) 7 dosya · $1K toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 2 (+1 önceki Ç'ye göre) | 1 (+1 önceki Ç'ye göre) | 1 (0 önceki Ç'ye göre) | 0 (0 önceki Ç'ye göre) | +12K |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| TWO SIGMA SECURITIES, LLC | $397 | 57.539 | 33,42% | Hisse senetleri |
| ARMISTICE CAPITAL, LLC | $345 | 50.000 | 29,04% | Hisse senetleri |
| Marex Group Ltd | $223 | 25.000 | 18,77% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $216 | 24.293 | 18,18% | Hisse senetleri |
| Clear Street Group Inc. | $3 | 380 | 0,25% | Hisse senetleri |
| CLEAR STREET LLC | $2 | 71 | 0,17% | Hisse senetleri |
| Kepos Capital LP | $2 | 334.600 | 0,17% | Hisse senetleri |
Şirket yöneticileri 1 içeriden öğrenen · 0 yöneticiler · 0 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Coastlands Capital LP | 10% sahip | 17 Haziran 2026 P | 3.835.035 | 1 | 0 | $53.000 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
Aktivistler ve %5+ sahipler 1 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Lawrence Steinman | 06 Mart 2025 | 3,10% | Değişiklik | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.